… for new treatment strategy, such as targeted therapy, immunotherapy, and … effect in the
treatment of cancer, RASi can also reduce the side effects of molecular targeted therapy in cancer …

… -classical roles in cancer, the notion of repurposing this class of medications as cancer
treatment(s) … Pharmacological targeting of the AT1R and ACE has been extremely effective in the …

… to enhance the effect of chemo-radiotherapy and targeted … treatment (chemo-radiotherapy
and targeted therapy). In the … of using RASi to enhance cancer treatment efficacy but also point …

… A high neutrophil-to-lymphocyte ratio has been shown to be associated with a poor treatment
effect of immunotherapy [49, 50]. In a model of pancreatic cancer, ARB administration was …

… Contrary to the Ang II effect in tumor immunity response, interesting findings also … that
targeting RAS could alleviate immunosuppression and enhance the outcome of immunotherapy. …

… reached statistical significance for gastrointestinal cancer (multivariable … therapy suggest
potential synergy between VEGF-targeted … Cancer immunotherapy using checkpoint blockade …

… target (Schietinger et al., 2008). In fact, immunotherapy has revolutionized cancer treatment
and … and other diseases as side effect of radiation therapy by lowering the dose of irradiation. …

… immunotherapies, such as chimeric antigen receptor T-cell therapy, and (4) immune checkpoint
blockers targeting … This study also shows the effect of RASIs is dependent on the cancer …

… or treated with ICI in combination with VEGF-targeted therapy … The additive effect of RASi
on systemic treatment in cancer … In mRCC, RASi improved survival in mRCC patients treated …

… to improve the efficacy and selectivity of current and future anticancer strategies targeting
renin-angiotensin systems. … significance of ACE2 and Mas receptor in human colon adenocar…